Rifampicin enhances activity of daptomycin and vancomycin against both a polysaccharide intercellular adhesin (PIA)-dependent and -independent Staphylococcus epidermidis biofilm

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 10, 2010, Pages 2164-2171

  Olson, Michael E ^a   Slater, Shawn R ^a   Rupp, Mark E ^a   Fey, Paul D ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Biomaterial infections; Guinea pig model; IcaADBC operon; Tissue cage

Indexed keywords

ADHESIN; DAPTOMYCIN; POLYSACCHARIDE INTERCELLULAR ADHESIN; RIFAMPICIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ARTICLE; BIOFILM; CELL VIABILITY; DRUG EFFICACY; GUINEA PIG; NONHUMAN; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; DAPTOMYCIN; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; GUINEA PIGS; MICROBIAL SENSITIVITY TESTS; POLYSACCHARIDES, BACTERIAL; RIFAMPIN; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; VANCOMYCIN; VIRULENCE FACTORS;

EID: 77957222902     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq314     Document Type: Article

References (50)

1. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32: 470-85.
2. Li H, Xu L, Wang J et al. Conversion of Staphylococcus epidermidis strains from commensal to invasive by expression of the ica locus encoding production of biofilm exopolysaccharide. Infect Immun 2005; 73: 3188-91.
3. Rupp ME, Fey PD, Heilmann C et al. Characterization of the importance of Staphylococcus epidermidis autolysin and polysaccharide intercellular adhesin in the pathogenesis of intravascular catheter-associated infection in a rat model. J Infect Dis 2001; 183: 1038-42.
4. Rupp ME, Ulphani JS, Fey PD et al. Characterization of the importance of polysaccharide intercellular adhesin/hemagglutinin of Staphylococcus epidermidis in the pathogenesis of biomaterial-based infection in a mouse foreign body infection model. Infect Immun 1999; 67: 2627-32.
5. Rupp ME, Ulphani JS, Fey PD et al. Characterization of Staphylococcus epidermidis polysaccharide intercellular adhesin/hemagglutinin in the pathogenesis of intravascular catheter-associated infection in a rat model. Infect Immun 1999; 67: 2656-9.
6. Heilmann C, Schweitzer O, Gerke C et al. Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol Microbiol 1996; 20: 1083-91.
7. Mack D, Fischer W, Krokotsch A et al. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J Bacteriol 1996; 178: 175-83.
8. Olson ME, Garvin KL, Fey PD et al. Adherence of Staphylococcus epidermidis to biomaterials is augmented by PIA. Clin Orthop Relat Res 2006; 451: 21-4.
9. Stevens NT, Sadovskaya I, Jabbouri S et al. Staphylococcus epidermidis polysaccharide intercellular adhesin induces IL-8 expression in human astrocytes via a mechanism involving TLR2. Cell Microbiol 2009; 11: 421-32.
10. Vuong C, Voyich JM, Fischer ER et al. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol 2004; 6: 269-75.
11. Cho SH, Naber K, Hacker J et al. Detection of the icaADBC gene cluster and biofilm formation in Staphylococcus epidermidis isolates from catheter-related urinary tract infections. Int J Antimicrob Agents 2002; 19: 570-5.
12. Frebourg NB, Lefebvre S, Baert S et al. PCR-based assay for discrimination between invasive and contaminating Staphylococcus epidermidis strains. J Clin Microbiol 2000; 38: 877-80.
13. Galdbart JO, Allignet J, Tung HS et al. Screening for Staphylococcus epidermidis markers discriminating between skin-flora strains and those responsible for infections of joint prostheses. J Infect Dis 2000; 182: 351-5.
14. Rohde H, Burandt EC, Siemssen N et al. Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. Biomaterials 2007; 28: 1711-20.
15. Ziebuhr W, Heilmann C, Gotz F et al. Detection of the intercellular adhesion gene cluster (ica) and phase variation in Staphylococcus epidermidis blood culture strains and mucosal isolates. Infect Immun 1997; 65: 890-6.
16. Qin Z, Ou Y, Yang L et al. Role of autolysin-mediated DNA release in biofilm formation of Staphylococcus epidermidis. Microbiology 2007; 153: 2083-92.
17. Rice KC, Mann EE, Endres JL et al. The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus. Proc Natl Acad Sci USA 2007; 104: 8113-8.
18. Rohde H, Burdelski C, Bartscht K et al. Induction of Staphylococcus epidermidis biofilm formation via proteolytic processing of the accumulation-associated protein by staphylococcal and host proteases. Mol Microbiol 2005; 55: 1883-95.
19. Lasa I, Penades JR. Bap: a family of surface proteins involved in biofilm formation. Res Microbiol 2006; 157: 99-107.
20. Christner M, Franke GC, Schommer NN et al. The giant extracellular matrix-binding protein of Staphylococcus epidermidis mediates biofilm accumulation and attachment to fibronectin. Mol Microbiol 2010; 75: 187-207.
21. Clarke SR, Harris LG, Richards RG et al. Analysis of Ebh, a 1.1-megadalton cell wall-associated fibronectin-binding protein of Staphylococcus aureus. Infect Immun 2002; 70: 6680-7.
22. Rani SA, Pitts B, Beyenal H et al. Spatial patterns of DNA replication, protein synthesis, and oxygen concentration within bacterial biofilms reveal diverse physiological states. J Bacteriol 2007; 189: 4223-33.
23. Stewart PS, Franklin MJ. Physiological heterogeneity in biofilms. Nat Rev Microbiol 2008; 6: 199-210.
24. Lewis K. Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol Immunol 2008; 322: 107-31.
25. Handke LD, Slater SR, Conlon KM et al. sB and SarA independently regulate polysaccharide intercellular adhesin production in Staphylococcus epidermidis. Can J Microbiol 2007; 53: 82-91.
26. Zimmerli W, Waldvogel FA, Vaudaux P et al. Pathogenesis of foreign body infection: description and characteristics of an animal model. J Infect Dis 1982; 146: 487-97.
27. Fey PD, Olson ME. Current concept in biofilm formation of Staphylococcus epidermidis. Future Microbiol 2010; 5: 917-933.
28. Alborn WE Jr, Allen NE, Preston DA. Daptomycin disrupts membrane potential in growing Staphylococcus aureus. Antimicrob Agents Chemother 1991; 35: 2282-7.
29. Silverman JA, Perlmutter NG, Shapiro HM. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob Agents Chemother 2003; 47: 2538-44.
30. LaPlante KL, Mermel LA. In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model. Nephrol Dial Transplant 2007; 22: 2239-46.
31. LaPlante KL, Woodmansee S. Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis. Antimicrob Agents Chemother 2009; 53: 3880-6.
32. Aubry-Damon H, Soussy CJ, Courvalin P. Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1998; 42: 2590-4.
33. Monzon M, Oteiza C, Leiva J et al. Synergy of different antibiotic combinations in biofilms of Staphylococcus epidermidis. J Antimicrob Chemother 2001; 48: 793-801.
34. Widmer AF, Frei R, Rajacic Z et al. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis 1990; 162: 96-102.
35. Aslam S, Trautner BW, Ramanathan V et al. Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters. Antimicrob Agents Chemother 2007; 51: 1556-8.
36. Trampuz A, Zimmerli W. Antimicrobial agents in orthopaedic surgery: prophylaxis and treatment. Drugs 2006; 66: 1089-105.
37. Archer GL, Johnston JL, Vazquez GJ et al. Efficacy of antibiotic combinations including rifampin against methicillin-resistant Staphylococcus epidermidis: in vitro and in vivo studies. Rev Infect Dis 1983; 5(Suppl 3): S538-42.
38. Mogenet I, Raetz-Dillon S, Canonge JM et al. Successful treatment of Staphylococcus epidermidis hip prosthesis infection with oral linezolid. Ann Pharmacother 2004; 38: 986-8.
39. Raad I, Alrahwan A, Rolston K. Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin Infect Dis 1998; 26: 1182-7.
40. Saginur R, St Denis M, Ferris Wet al. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrob Agents Chemother 2006; 50: 55-61.
41. Saleh-Mghir A, Ameur N, Muller-Serieys C et al. Combination of quinupristin-dalfopristin (Synercid) and rifampin is highly synergistic in experimental Staphylococcus aureus joint prosthesis infection. Antimicrob Agents Chemother 2002; 46: 1122-4.
42. Widmer AF, Gaechter A, Ochsner PE et al. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin Infect Dis 1992; 14: 1251-3.
43. Zimmerli W, Widmer AF, Blatter M et al. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 1998; 279: 1537-41.
44. Lemmen SW, Hafner H, Klik S et al. Comparison of the bactericidal activity of moxifloxacin and levofloxacin against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli and Klebsiella pneumoniae. Chemotherapy 2003; 49: 33-5.
45. Darouiche RO, Dhir A, Miller AJ et al. Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria. J Infect Dis 1994; 170: 720-3.
46. Dunne WM Jr, Mason EO Jr, Kaplan SL. Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother 1993; 37: 2522-6.
47. Jefferson KK, Goldmann DA, Pier GB. Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms. Antimicrob Agents Chemother 2005; 49: 2467-73.
48. Rani SA, Pitts B, Stewart PS. Rapid diffusion of fluorescent tracers into Staphylococcus epidermidis biofilms visualized by time lapse microscopy. Antimicrob Agents Chemother 2005; 49: 728-32.
49. Stewart PS, Davison WM, Steenbergen JN. Daptomycin rapidly penetrates a Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother 2009; 53: 3505-7.
50. Zheng Z, Stewart PS. Penetration of rifampin through Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 2002; 46: 900-3.